Cell adhesion signals regulate the nuclear receptor activity.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
03 12 2019
Historique:
pubmed: 20 11 2019
medline: 14 4 2020
entrez: 20 11 2019
Statut: ppublish

Résumé

Cell adhesion is essential for proper tissue architecture and function in multicellular organisms. Cell adhesion molecules not only maintain tissue integrity but also possess signaling properties that contribute to diverse cellular events such as cell growth, survival, differentiation, polarity, and migration; however, the underlying molecular basis remains poorly defined. Here we identify that the cell adhesion signal initiated by the tight-junction protein claudin-6 (CLDN6) regulates nuclear receptor activity. We show that CLDN6 recruits and activates Src-family kinases (SFKs) in second extracellular domain-dependent and Y196/200-dependent manners, and SFKs in turn phosphorylate CLDN6 at Y196/200. We demonstrate that the CLDN6/SFK/PI3K/AKT axis targets the AKT phosphorylation sites in the retinoic acid receptor γ (RARγ) and the estrogen receptor α (ERα) and stimulates their activities. Interestingly, these phosphorylation motifs are conserved in 14 of 48 members of human nuclear receptors. We propose that a similar link between diverse cell adhesion and nuclear receptor signalings coordinates a wide variety of physiological and pathological processes.

Identifiants

pubmed: 31740618
pii: 1913346116
doi: 10.1073/pnas.1913346116
pmc: PMC6900646
doi:

Substances chimiques

Claudins 0
ESR1 protein, human 0
Estrogen Receptor alpha 0
Receptors, Cytoplasmic and Nuclear 0
Receptors, Retinoic Acid 0
Tyrosine 42HK56048U
src-Family Kinases EC 2.7.10.2
Proto-Oncogene Proteins c-akt EC 2.7.11.1
claudin 6 MRC5FX426I

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

24600-24609

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Science. 1995 Dec 1;270(5241):1491-4
pubmed: 7491495
Genes Dev. 2000 Jan 15;14(2):121-41
pubmed: 10652267
J Cell Biol. 1997 Nov 3;139(3):735-47
pubmed: 9348290
Mol Cell Biol. 1997 Jun;17(6):3013-20
pubmed: 9154799
J Cell Biol. 1998 Oct 19;143(2):391-401
pubmed: 9786950
Genes Dev. 2013 Apr 15;27(8):819-35
pubmed: 23630073
Nat Commun. 2019 Feb 18;10(1):816
pubmed: 30778075
Cell. 2003 Feb 21;112(4):535-48
pubmed: 12600316
J Biol Chem. 1999 Apr 30;274(18):12945-9
pubmed: 10212286
PLoS Comput Biol. 2013 Apr;9(4):e1003012
pubmed: 23637584
Nat Rev Mol Cell Biol. 2011 Mar;12(3):189-97
pubmed: 21346732
Mol Endocrinol. 1995 Jul;9(7):860-71
pubmed: 7476969
FEBS Lett. 2000 Jul 7;476(3):258-61
pubmed: 10913624
Blood. 2017 Oct 5;130(14):1607-1619
pubmed: 28794070
EMBO J. 1996 May 1;15(9):2174-83
pubmed: 8641283
Nature. 1995 Oct 5;377(6548):397-404
pubmed: 7566114
Nature. 1995 Dec 14;378(6558):681-9
pubmed: 7501014
Exp Cell Res. 2003 Jun 10;286(2):288-97
pubmed: 12749857
Science. 1996 Dec 20;274(5295):2100-3
pubmed: 8953045
J Cell Sci. 2013 Jan 15;126(Pt 2):393-401
pubmed: 23525005
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W184-7
pubmed: 15980451
Biochim Biophys Acta. 2008 Mar;1778(3):588-600
pubmed: 17916321
FASEB J. 2008 Jan;22(1):146-58
pubmed: 17761522
FASEB J. 1996 Jul;10(9):940-54
pubmed: 8801176
J Cell Biol. 1998 Jun 29;141(7):1539-50
pubmed: 9647647
J Biol Chem. 2009 Jul 10;284(28):18863-72
pubmed: 19429681
Cell. 1996 Feb 9;84(3):345-57
pubmed: 8608588
Exp Cell Res. 2001 Feb 1;263(1):163-72
pubmed: 11161715
Pharmacol Rev. 2006 Dec;58(4):760-72
pubmed: 17132853
Nature. 1995 Oct 5;377(6548):454-7
pubmed: 7566127
Nat Rev Mol Cell Biol. 2016 Sep;17(9):564-80
pubmed: 27353478
J Biol Chem. 2010 Jan 1;285(1):401-8
pubmed: 19903817
Annu Rev Physiol. 2006;68:403-29
pubmed: 16460278
Ann N Y Acad Sci. 2012 Jun;1257:45-53
pubmed: 22671588
J Cell Biol. 2006 Dec 18;175(6):971-80
pubmed: 17178913
Mol Cell Biol. 2010 Jan;30(1):231-44
pubmed: 19884340
Cell. 2002 Sep 20;110(6):673-87
pubmed: 12297042
Nature. 1981 May 21;291(5812):235-7
pubmed: 6164928
Cell. 2010 Dec 23;143(7):1174-89
pubmed: 21183079
Oncogene. 2004 Oct 18;23(48):7979-89
pubmed: 15489915
Cell. 2006 Nov 3;127(3):635-48
pubmed: 17081983
Mol Biol Cell. 2007 Aug;18(8):3214-23
pubmed: 17553930
Trends Cell Biol. 2006 Apr;16(4):181-8
pubmed: 16537104
PLoS One. 2013 Oct 08;8(10):e75106
pubmed: 24116027
Nat Cell Biol. 2019 Feb;21(2):251-262
pubmed: 30664792
Nat Rev Mol Cell Biol. 2015 Feb;16(2):110-23
pubmed: 25560970
Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):14930-5
pubmed: 22927406
Exp Cell Res. 2005 Oct 15;310(1):66-78
pubmed: 16098509
EMBO J. 1999 Sep 1;18(17):4608-18
pubmed: 10469641
Cell. 2014 Mar 27;157(1):255-66
pubmed: 24679540
Nat Struct Biol. 1998 Mar;5(3):199-202
pubmed: 9501913
Biochim Biophys Acta. 2008 Mar;1778(3):631-45
pubmed: 18036336
Genes Dev. 2009 Feb 15;23(4):397-418
pubmed: 19240129
Science. 2010 Sep 3;329(5996):1205-10
pubmed: 20813954
Trends Biochem Sci. 2019 Feb;44(2):141-152
pubmed: 30665499

Auteurs

Kotaro Sugimoto (K)

Department of Basic Pathology, Fukushima Medical University School of Medicine, 960-1295 Fukushima, Japan.

Naoki Ichikawa-Tomikawa (N)

Department of Basic Pathology, Fukushima Medical University School of Medicine, 960-1295 Fukushima, Japan.

Korehito Kashiwagi (K)

Department of Basic Pathology, Fukushima Medical University School of Medicine, 960-1295 Fukushima, Japan.

Chihiro Endo (C)

Department of Basic Pathology, Fukushima Medical University School of Medicine, 960-1295 Fukushima, Japan.

Satoshi Tanaka (S)

Department of Pathology, Sapporo Medical University School of Medicine, 060-8556 Sapporo, Japan.

Norimasa Sawada (N)

Department of Pathology, Sapporo Medical University School of Medicine, 060-8556 Sapporo, Japan.

Tetsuya Watabe (T)

Department of Basic Pathology, Fukushima Medical University School of Medicine, 960-1295 Fukushima, Japan.

Tomohito Higashi (T)

Department of Basic Pathology, Fukushima Medical University School of Medicine, 960-1295 Fukushima, Japan.

Hideki Chiba (H)

Department of Basic Pathology, Fukushima Medical University School of Medicine, 960-1295 Fukushima, Japan; hidchiba@fmu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH